Exome-based sequencing is a powerful approach for studying rare genetic diseases. A new study now applies this technology to demonstrate an important role for de novo mutations in sporadic mental retardation.
This is a preview of subscription content, log in via an institution to check access.
References
Vissers, L.E.L.M. et al. Nat. Genet. 42, 1109–1112 (2010).
Lupski, J.R. Nat. Genet. 39, S43–S47 (2007).
Lu, X.Y. et al. Pediatrics 122, 1310–1318 (2008).
Zlotogora, J. Hum. Genet. 102, 381–386 (1998).
Notini, A.J., Craig, J.M. & White, S.J. Cytogenet. Genome Res. 123, 270–277 (2008).
Vadlamudi, L. et al. N. Engl. J. Med. 363, 1335–1340 (2010).
Zhang, F. et al. Nat. Genet. 41, 849–853 (2009).
Lee, J.A., Carvalho, C.M. & Lupski, J.R. Cell 131, 1235–1247 (2007).
Crespi, B., Stead, P. & Elliot, M. Proc. Natl. Acad. Sci. USA 107 Suppl 1, 1736–1741 (2010).
Shinawi, M. et al. J. Med. Genet. 47, 332–341 (2010).
Brunetti-Pierri, N. et al. Nat. Genet. 40, 1466–1471 (2008).
Galhardo, R.S., Hastings, P.J. & Rosenberg, S.M. Crit. Rev. Biochem. Mol. Biol. 42, 399–435 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares competing financial interests. Details accompany the full-text HTML version of the paper at http://www.nature.com/naturegenetics/.
Rights and permissions
About this article
Cite this article
Lupski, J. New mutations and intellectual function. Nat Genet 42, 1036–1038 (2010). https://doi.org/10.1038/ng1210-1036
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1210-1036
- Springer Nature America, Inc.
This article is cited by
-
Evaluating the Role of MAST1 as an Intellectual Disability Disease Gene: Identification of a Novel De Novo Variant in a Patient with Developmental Disabilities
Journal of Molecular Neuroscience (2020)
-
Identification of novel candidate disease genes from de novo exonic copy number variants
Genome Medicine (2017)